Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6 | 18 | 75 | 75 | 128 |
| Receivables | 18 | 16 | 9 | 23 | 17 |
| Other current assets | 5 | 5 | 21 | 36 | 0 |
| TOTAL | $30 | $39 | $110 | $147 | $200 |
| Non-Current Assets | |||||
| Intangibles | 527 | 540 | 552 | 565 | 565 |
| TOTAL | $527 | $540 | $552 | $565 | $565 |
| Total Assets | $557 | $578 | $662 | $712 | $765 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,490 | 1,434 | 1,380 | 1,349 | 1,402 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 370 | 343 |
| Accrued Expenses | N/A | N/A | N/A | 237 | 327 |
| TOTAL | $2,067 | $2,001 | $2,001 | $1,956 | $2,071 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -120 | -130 | -142 | -159 | -172 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,067 | $2,001 | $2,001 | $1,956 | $2,071 |
| Shareholders' Equity | |||||
| Common Shares | 34,015 | 34,015 | 34,015 | 33,990 | 34,048 |
| Retained earnings | -39,357 | -39,280 | -39,207 | -39,107 | -39,097 |
| Other shareholders' equity | 3,713 | 3,713 | 3,711 | 3,714 | 3,570 |
| TOTAL | $-1,630 | $-1,552 | $-1,481 | $-1,403 | $-1,479 |
| Total Liabilities And Equity | $437 | $449 | $520 | $553 | $593 |